Below benchmark for 1st month, page-49

Add the potential of Parkinson's, Alzheimer and Huntington's disease to the list and we are talking potential blockbuster status. Because of the great safety profile it will lend itself to off label usage and alternative trials without drama. We need a partnership with the big boys because they will be best placed to find every possible angle to use Trofinetide.

Anther thought I had was around spinal injury. If they can get the TBI trial to work, I wonder if it would also have potential to treat spinal cord inflammation post injury. My understanding is that post traumatic inflammation can substantially worsen outcomes.

So if we can get some P2 trials to show all this works the SP might get to 7c!